Wednesday, August 1, 2018

The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Celgene (CELG), Exxon Mobil (XOM) and Berkshire Hathaway (BRK.B). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Buy-ranked Celgene’s shares have underperformed the Zacks Biomedical and Genetics industry in the last three months, gaining +3.6% vs. +10.0%. Celgene’s second-quarter results were impressive as the company beat on both sales and earnings. Revlimid sales were impressive yet again, along with Pomalyst and Otezla.

The increase in annual guidance on the back of Revlimid sales should boost investors’ sentiment, given the recent spate of pipeline setbacks. The company is focused on the next cycle of innovation with five late stage candidates. In a bid to revive its pipeline, Celgene acquired Juno Therapeutics and added JCAR017 to its lymphoma pipeline.

Celgene expects to submit its NDA for fedratinib in myelofibrosis by the end of 2018. The company remains on track with submissions for ozanimod, both in the United States and EU, for relapsing multiple sclerosis in the first quarter of 2019.

(You can read the full research report on Celgene here >>>).

Shares of Exxon Mobil have gained +6.1% in the last three months, outperforming the Zacks Oil and Gas – Integrated industry, which gained +2.0% over the same period. The company has a leading position in the energy industry owing to the size and diversity of its asset base, both in terms of business mix and geographical footprint.

With a stable cash position, the company’s balance sheet is one of the best in the industry. This has allowed ExxonMobil to reward stockholders with a 6.3% average annual dividend hike over the past 35 years. The company owns some of the most prolific upstream assets globally along with the largest global refining operations.

Notably, ExxonMobil continues to gain on ramped-up oil-equivalent production from Hebron field. However, significant turnaround activities, hurting throughput volumes, led to lower-than-expected results in the second quarter. Moreover, ExxonMobil’s exit from a joint venture in Russia could limit the company’s upside.

(You can read the full research report on Exxon Mobil here >>>).

Buy-ranked Berkshire Hathaway’s shares have outperformed the Zacks Insurance – Property and Casualty industry over the past year (+11.2% vs. 8.9%). Berkshire’s inorganic growth story remains impressive with strategic acquisitions. A strong cash position allows it to make earnings-accretive bolt-on acquisitions.

Demand for utilities is expected to rise in the future and drive earnings growth. Continued insurance business growth also fuels increase in float. A sturdy capital level further adds an impetus to the company. The insurance business generates maximum return on equity but its exposure to catastrophe loss remains a concern. Huge capital expenses due to railroad operations also emerge as headwinds. Capital expenditure is estimated at $10 billion in 2018.

(You can read the full research report on Berkshire Hathaway here >>>).

Other noteworthy reports we are featuring today include International Paper (IP), Phillips 66 (PSX) and VMware (VMW).

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we’re targeting>>

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Featured Reports

Rising Geothermal Energy, Energy Storage Market Aids Ormat (ORA)

As per Zacks Analyst, the company can thrive in the global geothermal energy market as it’s expected to grow from 13.8 GW in 2017 to 23 GW by 2021.

High Product Demand & Growth Initiatives Aid Allison (ALSN)

Per the Zacks analyst, increased demand for on and off-highway products from global customers and its ongoing growth initiatives across the end market drive Allison’s financials.

Donaldson (DCI) Grows on Robust Industrial & Engine Business

Per the Zacks Analysts, robust Engine Product and Industrial Product revenues, strong liquidity and latest Hy-Pro buyout will likely boost Donaldson’s near-term results.

Europe & Asia Regions to Continue Driving Guess’ (GES) Sales

Per the Zacks analyst, solid Europe and Asia sales have been long driving Guess’ Management plans to invest more in these regions.

Dull Global Business Ails Hill-Rom (HRC), New Launches Aid

The Zacks analyst is worried about tough comparisons in the Middle East and dull OEM revenue hurting Hill-Rom’s global sales.

Hyatt (H) Rides on Asset Recycling Program Amid Competition

Per the Zacks analyst, Hyatt’s strategy of asset recycling is helping in terms of strengthening liquidity and protecting current liabilities.

Aerospace Segment to Drive Woodward’s (WWD) Revenues

Per the Zacks analyst, strong traction of Woodward’s Aerospace Segment should continue to drive its revenues.

New Upgrades

KLA-Tenor’s (KLAC) Innovative Products Continue to Drive Growth

The Zacks analyst believes that KLA’s comprehensive product line, growth in China and the increasing process control spending across foundry, memory and logic players offer higher growth potential.

Solid Demand, Acquisitions to Boost International Paper (IP)

Per the Zacks analyst, International Paper will gain from healthy demand across its segments. The acquisition of Weyerhaeuser’s pulp business will fortify its position in the global fluff pulp market

Phillips 66 (PSX) to Benefit From Sweeny Hub NGL Expansion

The Zacks analyst believes that Phillips 66’s (PSX) Sweeny Hub expansion project in Texas Gulf Coast offers strong growth potential to the company’s Midstream business.

New Downgrades

Margin Pressure, Elevated Costs Hurt Hilltop Holdings (HTH)

Per the Zacks analyst, pressure on Hilltop Holdings’ net interest margin (despite higher rates) and lower mortgage volumes are likely to hurt revenues. Also, higher expense levels remain a concern.

VMware (VMW) Hurt By Rising Spending Amid Stiff Competition

Per the Zacks analyst, heavy spending on R&D amid intensifying competition is expected to keep VMware’s margins under pressure.

Xerox (XRX) Hurt by Lower Demand for Paper Related Products

The Zacks analyst believes that decreasing demand for paper-related systems and products due to technological advancements is expected to hurt Xerox.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Exxon Mobil Corporation (XOM): Free Stock Analysis Report
 
Vmware, Inc. (VMW): Free Stock Analysis Report
 
Phillips 66 (PSX): Free Stock Analysis Report
 
International Paper Company (IP): Free Stock Analysis Report
 
Celgene Corporation (CELG): Free Stock Analysis Report
 
Berkshire Hathaway Inc. (BRK.B): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research